Articles dans des revues avec comité de lecture (50)

  1. 35. Vertongen, P., Delhase, M., Rajas, F., Trouillas, J., Peters, E., Svoboda, M., & Robberecht, P. (1996). Pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes are differently expressed in rat transplanted pituitary tumours (SMtTW) and in the normal gland. Journal of molecular endocrinology, 16(3), 239-248.
  2. 36. Vertongen, P., Devalck, C., Sariban, E., De Laet, M.-H., Martelli, H., Paraf, F., Hélardot, P., & Robberecht, P. (1996). Pituitary adenylate cyclase activating peptide and its receptors are expressed in human neuroblastomas. Journal of cellular physiology, 167(1), 36-46. doi:10.1002/(SICI)1097-4652(199604)167:1<36::AID-JCP4>3.0.CO;2-D
  3. 37. Robberecht, P., Gourlet, P., Vertongen, P., & Svoboda, M. (1996). Characterization of the VIP receptor from SUP T1 lymphoblasts. Advances in neuroimmunology, 6(1), 49-57. doi:10.1016/S0960-5428(96)00006-X
  4. 38. Van Laethem, J.-L., Devière, J., Grégoire, A., Rickaert, F., Vertongen, P., Ohtani, H., Cremer, M., Miyazono, K., & Robberecht, P. (1995). Localization of transforming growth factor beta 1 and its latent binding protein in human chronic pancreatitis. Gastroenterology, 108(6), 1873-1881.
  5. 39. Delporte, C., Poloczek, P., De Neef, P., Vertongen, P., Ciccarelli, E., Svoboda, M., Herchuelz, A., Winand, J., & Robberecht, P. (1995). Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide stimulate two signaling pathways in CHO cells stably transfected with the selective type I PACAP receptor. Molecular and cellular endocrinology, 107(1), 71-76. doi:10.1016/0303-7207(94)03424-R
  6. 40. Van Laethem, J.-L., Vertongen, P., Devière, J., Van Rampelbergh, J., Richaert, F., Cremer, M., & Robberecht, P. (1995). Detection of c-Ki-ras gene codon 12 mutations from pancreatic duct brushings in the diagnosis of pancreatic tumours. Gut, 36(5), 781-787.
  7. 41. Vertongen, P., Velkeniers, B., Peters, E., & Robberecht, P. (1995). Differential alternative splicing of PACAP receptor in pituitary cell subpopulations. Molecular and cellular endocrinology, 113(2), 131-135. doi:10.1016/0303-7207(95)03626-I
  8. 42. Vertongen, P., D'haens, J.-H., Michotte, A., Velkeniers, B., Van Rampelbergh, J., Svoboda, M., & Robberecht, P. (1995). Expression of pituitary adenylate cyclase activating polypeptide and receptors in human brain tumors. Peptides, 16(4), 713-719. doi:10.1016/0196-9781(95)00036-J
  9. 43. Vertongen, P., Ciccarelli, E., Woussen Colle, M.-C., De Neef, P., Robberecht, P., & Cauvin, A. (1994). Pituitary adenylate cyclase-activating polypeptide receptors of types I and II and glucagon-like peptide-I receptors are expressed in the rat medullary carcinoma of the thyroid cell line 6/23. Endocrinology, 135(4), 1537-1542. doi:10.1210/endo.135.4.7925114
  10. 44. Robberecht, P., De Neef, P., Woussen Colle, M.-C., Vertongen, P., De Witte, O., & Brotchi, J. (1994). Presence of calcitonin gene-related peptide receptors coupled to adenylate cyclase in human gliomas. Regulatory peptides, 52(1), 53-60.
  11. 45. Robberecht, P., Woussen Colle, M.-C., Vertongen, P., De Neef, P., Hou, X., Salmon, I., & Brotchi, J. (1994). Expression of pituitary adenylate cyclase activating polypeptide (PACAP) receptors in human glial cell tumors. Peptides, 15(4), 661-665.
  12. 46. Svoboda, M., Tastenoy, M., Vertongen, P., & Robberecht, P. (1994). Relative quantitative analysis of glucagon receptor mRNA in rat tissues. Molecular and cellular endocrinology, 105(2), 131-137. doi:10.1016/0303-7207(94)90162-7

  13. << Précédent 1 2 3 4 5 Suivant >>